.OncoC4 is taking AcroImmune-- and also its in-house professional manufacturing functionalities-- un...
.Amgen has discussed (PDF) the first phase 3 information on its own $400 million chronic eczema medi...
.Biogen and UCB's depend developing right into stage 3 on the back of an unsuccessful study tries to...
.Italian biotech Aptadir Therapies has released along with the assurance that its pipeline of precli...
.Wave Life Sciences has met its target in a Duchenne muscular dystrophy (DMD) research study, instal...
.After a few years in biotech, Mike Quigley, Ph.D., is actually coming back to the pharma crease, ta...
.Achilles Therapies has shreded its approach. The English biotech is actually stopping work on its c...
.Aligos Rehabs is actually trumpeting a midstage gain in metabolic-dysfunction linked steatohepatiti...
.Basilea Pharmaceutica's work developing brand new antifungals has obtained a substantial improvemen...
.Having currently gathered up the USA rights to Capricor Therapeutics' late-stage Duchenne muscle dy...